272 related articles for article (PubMed ID: 16762632)
41. Transient receptor potential vanilloid 1 gene deficiency ameliorates hepatic injury in a mouse model of chronic binge alcohol-induced alcoholic liver disease.
Liu H; Beier JI; Arteel GE; Ramsden CE; Feldstein AE; McClain CJ; Kirpich IA
Am J Pathol; 2015 Jan; 185(1):43-54. PubMed ID: 25447051
[TBL] [Abstract][Full Text] [Related]
42. Transmembrane signaling pathway mediates oxidized low-density lipoprotein-induced expression of plasminogen activator inhibitor-1 in vascular endothelial cells.
Sangle GV; Zhao R; Shen GX
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1243-54. PubMed ID: 18796547
[TBL] [Abstract][Full Text] [Related]
43. Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1.
Sato Y; Dong J; Imagawa S; Ishimori N; Furumoto T; Tsutsui H; Sobel BE; Fujii S
Coron Artery Dis; 2008 Aug; 19(5):355-61. PubMed ID: 18607173
[TBL] [Abstract][Full Text] [Related]
44. Increased dietary fat contributes to dysregulation of the LKB1/AMPK pathway and increased damage in a mouse model of early-stage ethanol-mediated steatosis.
Shearn CT; Smathers RL; Jiang H; Orlicky DJ; Maclean KN; Petersen DR
J Nutr Biochem; 2013 Aug; 24(8):1436-45. PubMed ID: 23465594
[TBL] [Abstract][Full Text] [Related]
45. Delayed ethanol elimination and enhanced susceptibility to ethanol-induced hepatosteatosis after liver resection.
Liu X; Hakucho A; Liu J; Fujimiya T
World J Gastroenterol; 2014 Dec; 20(48):18249-59. PubMed ID: 25561792
[TBL] [Abstract][Full Text] [Related]
46. Oral metformin-ascorbic acid co-administration ameliorates alcohol-induced hepatotoxicity in rats.
Adeneye AA; Benebo AS
Nig Q J Hosp Med; 2007; 17(4):155-9. PubMed ID: 18320763
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
Hu PF; Zhu YW; Zhong W; Chen YX; Lin Y; Zhang X; Yin C; Yue HY; Xie WF
J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
[TBL] [Abstract][Full Text] [Related]
48. Inflammation is independent of steatosis in a murine model of steatohepatitis.
Wang W; Xu MJ; Cai Y; Zhou Z; Cao H; Mukhopadhyay P; Pacher P; Zheng S; Gonzalez FJ; Gao B
Hepatology; 2017 Jul; 66(1):108-123. PubMed ID: 28220523
[TBL] [Abstract][Full Text] [Related]
49. Metformin, but not thiazolidinediones, inhibits plasminogen activator inhibitor-1 production in human adipose tissue in vitro.
He G; Pedersen SB; Bruun JM; Lihn AS; Richelsen B
Horm Metab Res; 2003 Jan; 35(1):18-23. PubMed ID: 12669266
[TBL] [Abstract][Full Text] [Related]
50. Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine 1-phosphate receptors.
Liu Y; Saiyan S; Men TY; Gao HY; Wen C; Liu Y; Zhou X; Wu CT; Wang LS; Cui CP
J Pathol; 2013 Aug; 230(4):365-76. PubMed ID: 23839903
[TBL] [Abstract][Full Text] [Related]
51. Metformin and the fate of fat.
Hoek JB
Gastroenterology; 2006 Jun; 130(7):2234-7. PubMed ID: 16762646
[No Abstract] [Full Text] [Related]
52. PAI-1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA.
Wang H; Zhang Y; Heuckeroth RO
FEBS Lett; 2007 Jun; 581(16):3098-104. PubMed ID: 17561000
[TBL] [Abstract][Full Text] [Related]
53. Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition.
Kaikita K; Fogo AB; Ma L; Schoenhard JA; Brown NJ; Vaughan DE
Circulation; 2001 Aug; 104(7):839-44. PubMed ID: 11502712
[TBL] [Abstract][Full Text] [Related]
54. Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis.
Flevaris P; Khan SS; Eren M; Schuldt AJT; Shah SJ; Lee DC; Gupta S; Shapiro AD; Burridge PW; Ghosh AK; Vaughan DE
Circulation; 2017 Aug; 136(7):664-679. PubMed ID: 28588076
[TBL] [Abstract][Full Text] [Related]
55. A combination of Pueraria lobata and Silybum marianum protects against alcoholic liver disease in mice.
Feng R; Chen JH; Liu CH; Xia FB; Xiao Z; Zhang X; Wan JB
Phytomedicine; 2019 May; 58():152824. PubMed ID: 30836218
[TBL] [Abstract][Full Text] [Related]
56. Tissue-type plasminogen activator is not necessary for platelet-derived growth factor-c activation.
Riehle KJ; Johnson MM; Johansson F; Bauer RL; Hayes BJ; Gilbertson DG; Haran AC; Fausto N; Campbell JS
Biochim Biophys Acta; 2014 Feb; 1842(2):318-25. PubMed ID: 24269585
[TBL] [Abstract][Full Text] [Related]
57. Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity.
Woo SL; Xu H; Li H; Zhao Y; Hu X; Zhao J; Guo X; Guo T; Botchlett R; Qi T; Pei Y; Zheng J; Xu Y; An X; Chen L; Chen L; Li Q; Xiao X; Huo Y; Wu C
PLoS One; 2014; 9(3):e91111. PubMed ID: 24638078
[TBL] [Abstract][Full Text] [Related]
58. Elevated activation of ERK1 and ERK2 accompany enhanced liver injury following alcohol binge in chronically ethanol-fed rats.
Aroor AR; Jackson DE; Shukla SD
Alcohol Clin Exp Res; 2011 Dec; 35(12):2128-38. PubMed ID: 21790671
[TBL] [Abstract][Full Text] [Related]
59. Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation.
Gupta KK; Donahue DL; Sandoval-Cooper MJ; Castellino FJ; Ploplis VA
Sci Rep; 2017 Mar; 7(1):365. PubMed ID: 28336948
[TBL] [Abstract][Full Text] [Related]
60. Sirtuin 5 promotes arterial thrombosis by blunting the fibrinolytic system.
Liberale L; Akhmedov A; Vlachogiannis NI; Bonetti NR; Nageswaran V; Miranda MX; Puspitasari YM; Schwarz L; Costantino S; Paneni F; Beer JH; Ruschitzka F; Montecucco F; Lüscher TF; Stamatelopoulos K; Stellos K; Camici GG
Cardiovasc Res; 2021 Aug; 117(10):2275-2288. PubMed ID: 32931562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
